REDUCE LAP-HF RANDOMIZED TRIAL I

NAActive, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

August 31, 2026

Conditions
Heart Failure
Interventions
DEVICE

Inter-Atrial Shunt Device

An implantable device placed in the interatrial septum

OTHER

Intracardiac Echo

Patients randomized to the control arm will undergo intra cardiac echocardiography, with examination of the atrial septum and left atrial appendage.

Trial Locations (21)

41809

University of Michigan Health System, Ann Arbor

55905

Mayo Clinic, Rochester

60201

Evanston Northshore Healthcare, Evanston

60611

Northwestern University, Chicago

70121

Ochsner Medical Center, New Orleans

85724

University of Arizona College of Medicine, Tucson

06510

Yale University, New Haven

Unknown

Cardiovascular Institute of the South, Houma

Massachusetts General Hospital, Boston

Columbia University Medical Center/NewYork Presbyterian Hospital, New York

Mt. Sinai Hospital, New York

New York University, New York

Wake Forest, Winston-Salem

Ohio Health, Columbus

Ohio State University College of Medicine, Columbus

University of Pennsylvania, Philadelphia

Medical University of South Carolina, Charleston

The Alfred Hospital, Melbourne

OLVZ Aalst, Aalst

UMC Groningen, Groningen

Golden Jubilee Hospital, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Corvia Medical

INDUSTRY

NCT02600234 - REDUCE LAP-HF RANDOMIZED TRIAL I | Biotech Hunter | Biotech Hunter